EcoR1 Capital as of March 31, 2021
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 70 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prothena Corp SHS Call Option (PRTA) | 12.6 | $284M | 11M | 25.12 | |
| Xencor (XNCR) | 9.4 | $211M | 4.9M | 43.06 | |
| Morphic Hldg (MORF) | 8.4 | $190M | 3.0M | 63.28 | |
| Anaptysbio Inc Common (ANAB) | 6.8 | $154M | 7.2M | 21.55 | |
| Nuvation Bio Com Cl A (NUVB) | 6.1 | $138M | 13M | 10.45 | |
| Relay Therapeutics (RLAY) | 5.3 | $119M | 3.4M | 34.57 | |
| Silverback Therapeutics (SPRY) | 4.9 | $111M | 2.5M | 43.63 | |
| Kura Oncology (KURA) | 4.6 | $104M | 3.7M | 28.27 | |
| Mirati Therapeutics | 3.5 | $80M | 464k | 171.30 | |
| Oric Pharmaceuticals (ORIC) | 3.4 | $76M | 3.1M | 24.50 | |
| Shattuck Labs (STTK) | 3.2 | $72M | 2.5M | 29.24 | |
| Nurix Therapeutics (NRIX) | 2.8 | $63M | 2.0M | 31.09 | |
| Arcus Biosciences Incorporated (RCUS) | 2.7 | $62M | 2.2M | 28.08 | |
| Solid Biosciences | 2.3 | $51M | 9.2M | 5.53 | |
| Avidity Biosciences Ord (RNA) | 2.0 | $46M | 2.1M | 21.81 | |
| Edgewise Therapeutics (EWTX) | 1.8 | $40M | 1.2M | 32.50 | |
| Neoleukin Therapeutics | 1.7 | $38M | 3.1M | 12.31 | |
| Atreca Cl A Com (BCEL) | 1.6 | $37M | 2.4M | 15.33 | |
| Design Therapeutics (DSGN) | 1.5 | $34M | 1.1M | 29.90 | |
| Gritstone Oncology Ord (GRTSQ) | 1.4 | $32M | 3.4M | 9.43 | |
| Ac Immune Sa SHS (ACIU) | 1.2 | $28M | 3.6M | 7.61 | |
| Akouos | 1.2 | $27M | 2.0M | 13.87 | |
| Ovid Therapeutics (OVID) | 1.1 | $24M | 6.1M | 4.02 | |
| Arvinas Ord (ARVN) | 0.9 | $21M | 319k | 66.10 | |
| Chinook Therapeutics | 0.9 | $19M | 1.3M | 15.54 | |
| Alector (ALEC) | 0.5 | $12M | 603k | 20.14 | |
| Eledon Pharmaceuticals (ELDN) | 0.5 | $12M | 1.1M | 10.70 | |
| Kronos Bio | 0.5 | $11M | 387k | 29.27 | |
| Applied Molecular Trans | 0.5 | $11M | 239k | 44.01 | |
| Allovir (ALVR) | 0.5 | $11M | 447k | 23.40 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.4 | $10M | 963k | 10.45 | |
| Translate Bio | 0.4 | $9.8M | 597k | 16.49 | |
| Bctg Acquisition Corp | 0.4 | $8.9M | 800k | 11.12 | |
| Iteos Therapeutics | 0.4 | $8.9M | 260k | 34.18 | |
| Alpine Immune Sciences | 0.3 | $7.9M | 741k | 10.60 | |
| Syros Pharmaceuticals | 0.3 | $7.5M | 1.0M | 7.48 | |
| C4 Therapeutics Com Stk (CCCC) | 0.3 | $7.4M | 200k | 36.99 | |
| Magenta Therapeutics | 0.3 | $6.6M | 556k | 11.84 | |
| Logicbio Therapeutics | 0.2 | $5.0M | 689k | 7.28 | |
| Bolt Biotherapeutics | 0.2 | $4.9M | 150k | 32.91 | |
| Jiya Acquisition Corp Com Cl A | 0.2 | $4.9M | 500k | 9.84 | |
| Cyclerion Therapeutics | 0.2 | $4.5M | 1.6M | 2.79 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.2 | $4.5M | 400k | 11.19 | |
| Ngm Biopharmaceuticals | 0.2 | $4.2M | 144k | 29.07 | |
| Kymera Therapeutics (KYMR) | 0.2 | $3.9M | 100k | 38.86 | |
| Dyne Therapeutics (DYN) | 0.1 | $3.3M | 215k | 15.53 | |
| Vincerx Pharma *w Exp 12/24/202 | 0.1 | $2.9M | 150k | 19.30 | |
| Aerpio Pharmaceuticals | 0.1 | $2.7M | 2.1M | 1.29 | |
| Bioatla (BCAB) | 0.1 | $2.5M | 50k | 50.84 | |
| Bcls Acquisition Corp Com Cl A | 0.1 | $2.1M | 200k | 10.57 | |
| Helix Acquisition Corp Com Cl A | 0.1 | $2.0M | 200k | 10.20 | |
| Frazier Lifesciences Acqu Unit 12/09/2025 | 0.1 | $2.0M | 200k | 10.16 | |
| 5 01 Acquisition Corp Com Cl A | 0.1 | $2.0M | 200k | 9.99 | |
| Eucrates Biomedical Acqu Cor SHS | 0.1 | $2.0M | 200k | 9.98 | |
| Consonance Hfw Acquisition C Unit 99/99/9999 | 0.1 | $2.0M | 200k | 9.76 | |
| Codiak Biosciences | 0.1 | $1.7M | 115k | 15.08 | |
| Pmv Pharmaceuticals (PMVP) | 0.1 | $1.6M | 50k | 32.90 | |
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.1 | $1.6M | 150k | 10.47 | |
| Repare Therapeutics Ord | 0.1 | $1.5M | 50k | 30.70 | |
| Fs Development Corp Ii Com Cl A | 0.1 | $1.5M | 150k | 9.96 | |
| Meiragtx Holdings (MGTX) | 0.1 | $1.4M | 95k | 14.43 | |
| Deerfield Healthcare Tech Ac *w Exp 07/16/202 | 0.1 | $1.2M | 100k | 12.12 | |
| Turmeric Acquisition Corp Cl A | 0.0 | $977k | 100k | 9.77 | |
| Kinnate Biopharma | 0.0 | $779k | 25k | 31.16 | |
| Eucrates Biomedical Acqu Cor *w Exp 10/23/202 | 0.0 | $665k | 67k | 9.98 | |
| Lifesci Acquisition Ii Corp | 0.0 | $573k | 57k | 10.14 | |
| F-star Therapeutics | 0.0 | $498k | 46k | 10.83 | |
| Omega Alpha Spac Cl A | 0.0 | $495k | 50k | 9.90 | |
| Metacrine Ord | 0.0 | $386k | 62k | 6.21 | |
| Turmeric Acquisition Corp *w Exp 10/08/202 | 0.0 | $326k | 33k | 9.78 |